These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 33712002

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nuclear beta catenin as a potential prognostic and diagnostic marker in patients with colorectal cancer from Hong Kong.
    Wong SC, Lo ES, Chan AK, Lee KC, Hsiao WL.
    Mol Pathol; 2003 Dec; 56(6):347-52. PubMed ID: 14645698
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical detection of p53 tumor suppressor gene protein in canine epithelial colorectal tumors.
    Wolf JC, Ginn PE, Homer B, Fox LE, Kurzman ID.
    Vet Pathol; 1997 Sep; 34(5):394-404. PubMed ID: 9381650
    [Abstract] [Full Text] [Related]

  • 7. [Expression of CD10 in tumor-associated fibroblast of cancerized or recurrent colorectal adenomas].
    Zheng J, Zhu Y, Li C, Li Y, Nie Q, Zhu Z, Deng H.
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May 25; 45(4):335-341. PubMed ID: 27868405
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Identification of marker genes and pathways specific to precancerous duodenal adenomas and early stage adenocarcinomas.
    Sakaguchi Y, Yamamichi N, Tomida S, Takeuchi C, Kageyama-Yahara N, Takahashi Y, Shiogama K, Inada KI, Ichinose M, Fujishiro M, Koike K.
    J Gastroenterol; 2019 Feb 25; 54(2):131-140. PubMed ID: 29951927
    [Abstract] [Full Text] [Related]

  • 14. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW, Choi H, So D, Kim YI, Cho K, Chung HJ, Lee KH, Chun YS, Cho CH, Kang GH, Kim WH, Park JW.
    Gastroenterology; 2014 Aug 25; 147(2):430-442.e8. PubMed ID: 24846398
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Expression of CD10 in cancer-associated fibroblasts and its effect on initiation and progression of colorectal carcinoma].
    Zhu Y, Zheng JJ, Yang F, Nie QQ, Zhu ZL, Deng H.
    Zhonghua Bing Li Xue Za Zhi; 2016 Dec 08; 45(12):859-865. PubMed ID: 28056302
    [Abstract] [Full Text] [Related]

  • 18. ß-Catenin, Cox-2 and p53 immunostaining in colorectal adenomas to predict recurrence after endoscopic polypectomy.
    Brand L, Munding J, Pox CP, Ziebarth W, Reiser M, Hüppe D, Schmiegel W, Reinacher-Schick A, Tannapfel A.
    Int J Colorectal Dis; 2013 Aug 08; 28(8):1091-8. PubMed ID: 23516071
    [Abstract] [Full Text] [Related]

  • 19. Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-Catenin in colorectal tumors.
    Takeda K, Kinoshita I, Shimizu Y, Ohba Y, Itoh T, Matsuno Y, Shichinohe T, Dosaka-Akita H.
    BMC Cancer; 2008 Nov 08; 8():328. PubMed ID: 18992165
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.